Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmology

The companies will jointly develop 4D bio-fabricated corneal transplants for diseases that require endothelial keratoplasty and natural lenticule transplants Carl Zeiss Meditec will invest in Precise Bio and fund the further development of Precise Bio's... Regenerative Medicine, Ophthalmology Precise Bio , Carl Zeiss Meditec
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news